Bank of Montreal
PTCT icon

Bank of Montreal’s PTC Therapeutics PTCT Stock Holding History

Bank of Montreal’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,000
Closed -$1.09M – 3862
2024
Q3 		$1.09M Buy
+29,000
New +$971K ﹤0.01% 1991
2017
Q2 		– Sell
-12,600
Closed -$124K – 4259
2017
Q1 		$124K Buy
+12,600
New +$153K ﹤0.01% 2711

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bank of Montreal's PTCT Position: Q2 2026 in Review

Bank of Montreal increased its PTC Therapeutics (PTCT) stake by 7.4% in Q2 2026, buying an estimated $44.5K and bringing the position to 8,911 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

Bank of Montreal first reported a position in PTCT in Q2 2014 and has held it in 33 quarters since. The position peaked at $8.13M in Q3 2024. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Bank of Montreal held 8,911 shares of PTC Therapeutics worth $727K as of Q2 2026.
  • Bank of Montreal bought 616 PTC Therapeutics shares in Q2 2026, an estimated $44.5K.
  • PTC Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2258 holding.
  • Bank of Montreal first reported a position in PTC Therapeutics in Q2 2014 and has held it in 33 quarters since.
  • Bank of Montreal's PTC Therapeutics position peaked at $8.13M in Q3 2024.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.